Plain-English translation of NCT07031089 on ClinicalTrials.gov ↗ ·
This study is tracking patients who have already had a liver stiffness test (Fibroscan) ordered by their primary care doctor because they showed signs of possible liver damage. Researchers want to see whether these patients are receiving the recommended follow-up care, including specialist visits and lifestyle changes to reduce their liver disease risk.
Liver damage often develops silently without symptoms, and by the time it's caught, it may be too late to prevent serious complications like cirrhosis or liver cancer. This study exists to make sure that when doctors do catch early signs of liver damage in regular clinics, patients actually get the specialized care and monitoring they need to prevent things from getting worse.
You likely qualify if…
You likely don't qualify if…
Researchers will review your medical records to see what happened after your liver stiffness test — whether you saw a specialist, received advice about reducing alcohol or managing weight, and whether you completed any recommended follow-up screening. You won't need to attend extra visits; the study simply tracks the care path you already received through your doctors.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
France